Trial Search Results
aTBS for Treatment of Depression in AUD
This study evaluates an accelerated schedule of theta-burst stimulation using a transcranial magnetic stimulation device for improvement of depressive symptoms and drinking behavior in individuals with alcohol dependence. In this open label study, all participants will receive accelerated theta-burst stimulation.
Stanford is currently not accepting patients for this trial.
- Device: Accelerated theta burst treatment
1. Participant aged 18-65 years old with diagnosis of alcohol use disorder.
2. Participant may also choose to or not to take pharmacotherapy during the study period.
3. Participant has tried at least one medication in the past that has not helped the
alcohol use disorder. If participants are taking medication, they must be on stable
psychotropic medication or psychotherapy for at least 6 weeks prior to the study with
plans to continue throughout study enrollment.
4. Participant needs to be at least one week after last alcohol/ substance use and had
the last drink within one year of the beginning of the study participation.
5. Participant endorses depressive symptom(s), indicated by a MARDS score >= 20.
6. All participants must be assigned to a psychiatrist and agree to continue to be
assigned to a psychiatrist throughout study enrollment.
7. Able to read, understand, and provide written, dated informed consent prior to
screening. Participants will be deemed likely to comply with study protocol and
communicate with study personnel about adverse events and other clinically important
Ages Eligible for Study
18 Years - 65 Years
Genders Eligible for Study